Samuel W Boellner

Summary

Publications

  1. ncbi Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder
    Samuel W Boellner
    Clinical Study Centers, Little Rock, Arkansas, USA
    Pharmacotherapy 27:1253-62. 2007
  2. ncbi Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study
    Samuel W Boellner
    Neurology and Clinical Study Center, Little Rock, AR 72205, USA
    Curr Med Res Opin 22:2457-65. 2006
  3. doi Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover
    Samuel W Boellner
    Clinical Study Centers, Little Rock, Arkansas, USA
    Clin Ther 32:252-64. 2010
  4. ncbi Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study
    Joseph Biederman
    Department of Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA 02114, USA
    Pediatrics 116:e777-84. 2005
  5. ncbi A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study
    Joseph Biederman
    Department of Pediatric Psychopharmacology, Massachusetts General Hospital, Boston 02114, USA
    J Clin Psychiatry 67:727-35. 2006
  6. ncbi A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder
    Joseph Biederman
    Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Pediatrics 110:258-66. 2002
  7. ncbi A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder
    Laurence L Greenhill
    New York State Psychiatric Institute, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 45:503-11. 2006
  8. ncbi Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study
    Joseph Biederman
    Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Biol Psychiatry 62:970-6. 2007
  9. doi Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder
    Timothy E Wilens
    Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Am Acad Child Adolesc Psychiatry 47:700-8. 2008

Detail Information

Publications9

  1. ncbi Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder
    Samuel W Boellner
    Clinical Study Centers, Little Rock, Arkansas, USA
    Pharmacotherapy 27:1253-62. 2007
    ..To evaluate the single- and multiple-dose pharmacokinetics of an oral extended-release formulation of guanfacine in children and adolescents with a diagnosis of attention-deficit-hyperactivity disorder (ADHD)...
  2. ncbi Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study
    Samuel W Boellner
    Neurology and Clinical Study Center, Little Rock, AR 72205, USA
    Curr Med Res Opin 22:2457-65. 2006
    ..To assess the continued efficacy of modafinil and obtain additional safety data, an 8-week, open-label study was conducted as an extension to the double-blind study...
  3. doi Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover
    Samuel W Boellner
    Clinical Study Centers, Little Rock, Arkansas, USA
    Clin Ther 32:252-64. 2010
    ..Information on the pharmacokinetic profile of LDX in children with ADHD is lacking...
  4. ncbi Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study
    Joseph Biederman
    Department of Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA 02114, USA
    Pediatrics 116:e777-84. 2005
    ..This study evaluated a new formulation of modafinil (modafinil film-coated tablets) in children and adolescents with ADHD...
  5. ncbi A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study
    Joseph Biederman
    Department of Pediatric Psychopharmacology, Massachusetts General Hospital, Boston 02114, USA
    J Clin Psychiatry 67:727-35. 2006
    ....
  6. ncbi A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder
    Joseph Biederman
    Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Pediatrics 110:258-66. 2002
    ..A secondary objective was to assess the diurnal variation in responses based on morning and afternoon assessments...
  7. ncbi A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder
    Laurence L Greenhill
    New York State Psychiatric Institute, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 45:503-11. 2006
    ..To evaluate the efficacy and tolerability of modafinil in children and adolescents, ages 7 to 17, with attention-deficit/hyperactivity disorder (ADHD)...
  8. ncbi Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study
    Joseph Biederman
    Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Biol Psychiatry 62:970-6. 2007
    ..Pharmacologically active d-amphetamine is released from lisdexamfetamine following oral ingestion...
  9. doi Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder
    Timothy E Wilens
    Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Am Acad Child Adolesc Psychiatry 47:700-8. 2008
    ..The objectives of this study were to determine the efficacy, duration of action, and safety of methylphenidate transdermal system worn for variable times by children (ages 6-12) diagnosed with ADHD...